Citations 0
Health Agencies Update
August 23/30, 2006

Once-Daily Anti-HIV Pill

JAMA. 2006;296(8):924. doi:10.1001/jama.296.8.924-d

The US Food and Drug Administration has approved the first once-a-day 3-drug combination for the treatment of HIV infection in adults (

Atripla combines the active ingredients of 3 widely used antiretroviral drugs: efavirenz, emtricitabine, and tenofovir disoproxil fumarate. The drug will be available for use in the United States as a new product approved under a New Drug Application and can be considered for purchase for use in 15 other countries included under the President's Emergency Plan for AIDS Relief program, a $15 billion initiative to fight the global HIV/AIDS pandemic.

First Page Preview View Large
First page PDF preview
First page PDF preview